AstraZeneca down after announcing its vaccine with Oxford achieved average efficacy of 70% Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Ideanomics (IDEX) up 33% after increasing its stake in Solectrac to 24% through a follow-on investment of an additional $1.3M
- Regeneron (REGN) up 3% after
announcing that the antibody cocktail casirivimab and imdevimab administered together, a therapy currently being investigated for use in COVID-19, has received Emergency Use Authorization from the FDA
UP AFTER EARNINGS -
- Huami (HMI) up 2%
- Korn/Ferry (KFY) up 4%
- Harbor Custom Development (HCDI) up 10%
DOWN AFTER EARNINGS -
- Baozun (BZUN) down 3%
- BioLineRx (BLRX) down 11%
- Twist Bioscience (TWST) down 1%
LOWER -
- AstraZeneca (AZN) down 2% after announcing that results from an interim analysis of clinical trials of AZD1222 in the U.K. and Brazil showed its vaccine with Oxford (OXBDF) had an average efficacy of 70% and that no hospitalizations or severe cases of the disease were reported in participants receiving the vaccine
- Kellogg (K) down 1% after Credit Suisse analyst Robert Moskow downgraded shares to Neutral from Outperform with a price target of $68, down from $77
Symbols:
IDEX AZN BLRX BZUN HCDIHarbor Custom Development
TWST KFY HMI REGN K Keywords: Fly Intel, Wall Street, Top Stories, Stocks